WO2026114983 - THERAPEUTIC COMBINATION COMPRISING N-{3-[4-AMINO-7-(1-METHYL-PIPERIDIN-4-YL)-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL]-2-FLUORO-PHENYL}-5-CHLORO-2-FLUORO-4-METHOXY-BENZENE SULFONAMIDE COMPOUND AND ANTINEOPLASTIC AGENTS
National phase entry is expected:
Publication Number
WO/2026/114983
Publication Date
04.06.2026
International Application No.
PCT/EP2025/084419
International Filing Date
26.11.2025
Title **
[English]
THERAPEUTIC COMBINATION COMPRISING N-{3-[4-AMINO-7-(1-METHYL-PIPERIDIN-4-YL)-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL]-2-FLUORO-PHENYL}-5-CHLORO-2-FLUORO-4-METHOXY-BENZENE SULFONAMIDE COMPOUND AND ANTINEOPLASTIC AGENTS
[French]
COMBINAISON THÉRAPEUTIQUE COMPRENANT LE COMPOSÉ N-{3-[4-AMINO-7-(1-MÉTHYL-PIPÉRIDIN-4-YL)-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL]-2-FLUORO-PHÉNYL}-5-CHLORO-2-FLUORO-4-MÉTHOXY-BENZÈNE SULFONAMIDE ET DES AGENTS ANTINÉOPLASIQUES
Applicants **
NERVIANO MEDICAL SCIENCES S.R.L.
Inventors
PERRERA, Claudia
MAHNKE, Lisa
CARENZI, Davide
LOMBARDI BORGIA, Andrea
Priority Data
24216599.1
29.11.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2662 | |
| EPO | Filing, Examination, Granting | 13710 | |
| Japan | Filing, Examination, Granting | 2400 | |
| South Korea | Filing, Examination, Granting | 2568 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
28,480
Contact Us
Abstract[English]
The present invention relates to combinations comprising N-{3-[4-Amino-7-(1-methyl-piperidin-4-yl)-7H-pyrrolo[2,3- d]pyrimidin-5-yl]-2-fluoro-phenyl}-5-chloro-2-fluoro-4-methoxy-benzenesulfonamide or its pharmaceutically acceptable salt and antineoplastic agents. The invention also relates to the use of said combination in the treatment of cancer.[French]
La présente invention concerne des combinaisons comprenant le N-{3-[4-amino-7-(1-méthyl-pipéridin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-fluoro-phényl}-5-chloro-2-fluoro-4-méthoxy-benzènesulfonamide ou son sel pharmaceutiquement acceptable et des agents antinéoplasiques. L'invention concerne également l'utilisation de ladite combinaison dans le traitement du cancer.